A new treatment approach for cystic fibrosis

Antisense oligonucleotides, or ASOs, are molecules that can be used to control protein levels in cells. Scientists have discovered a new way ASOs may help cells produce a protein missing in cystic fibrosis (CF) patients. The discovery sets the stage for a new therapeutic approach that may help reduce CF symptoms and improve patients' quality of life.